We have recently demonstrated that mGluR5 positive allosteric modulators (PAMs) preferentially activate neuroprotective cell signaling pathways and prevent neuronal cell death in primary cultured striatal neurons, as well as in a mouse model of Huntington’s disease (HD) [10, 11]. This evidence concerns the gene GRM5 and Huntington disease.